CymaBay Therapeutics' Series B - III Round

CymaBay Therapeutics raised a round of funding on December 16, 2004.

CymaBay Therapeutics, formerly Metabolex, is a privately-held biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, w…

Articles about CymaBay Therapeutics' Series B - III Round: